Oncology


26 results

Oncology

Latest news on the cabozantinib program

17 October 2016

Ipsen and its partner Exelixis will jointly host a live investor briefing at the 2018…

Oncology

Positive CHMP opinion for CabometyxTM (cabozantin...

22 July 2016

Ipsen and its partner Exelixis will jointly host a live investor briefing at the 2018…

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved - 2023